Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

XKON/086220 stock hub

XKON/086220 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/086220is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.6B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/086220

In the news

Latest news · XKON/086220

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-4.1

P25 n/aP50 n/aP75 n/a

ROIC3.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/086220 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

KRW

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	81
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 17.6B
Price	KRW 1,385
Price currency	KRW
Rev Per Employee	470,325,341.98x
Sic	2834
Symbol	xkon/086220
Website	https://www.kdhealthbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.84%
FCF yield	1.99%
P/B ratio	1.49x
P/S ratio	0.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.69%
EBITDA Margin	6.97%
FCF margin	0.92%
Gross margin	13.27%
Gross Profit	KRW 5.1B
Gross Profit Growth	-14.34%
Gross Profit Growth3 Y	-5.8%
Gross Profit Growth5 Y	-8.09%
Net Income	KRW -323.5M
Pretax Margin	-0.73%
Profit Margin	-0.85%
Profit Per Employee	KRW -4M
ROA	1.62
Roa5y	2.21
ROCE	7.35
ROE	-4.15
Roe5y	-3.48
ROIC	3.4
Roic5y	3.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	2.59%
Cagr3y	-12.43%
Cagr5y	-8.31%
FCF Growth5 Y	-30.39%
OCF Growth3 Y	-49.6%
OCF Growth5 Y	-26.1%
Revenue Growth	-2.5x
Revenue Growth3 Y	0.76x
Revenue Growth5 Y	-4.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.96
Assets	KRW 39.3B
Cash	KRW 1.3B
Current Assets	KRW 12.1B
Current Liabilities	KRW 33.4B
Debt	KRW 19.5B
Debt EBITDA	KRW 7.33
Debt Equity	KRW 1.64
Debt FCF	KRW 55.56
Equity	KRW 11.8B
Interest Coverage	1.07
Liabilities	KRW 27.4B
Long Term Assets	KRW 27.2B
Long Term Liabilities	KRW -6B
Net Cash	KRW -18.2B
Net Cash By Market Cap	KRW -103
Net Debt EBITDA	KRW 6.85
Net Debt Equity	KRW 1.54
Net Debt FCF	KRW 51.91
Tangible Book Value	KRW 11.4B
Tangible Book Value Per Share	KRW 2,010
WACC	3.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.52
Inventory Turnover	6.5
Net Working Capital	KRW 5.2B
Quick ratio	0.22
Working Capital	KRW -12B
Working Capital Turnover	KRW -2.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	33.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	2.58%
200-day SMA	1,427.2
3Y total return	-32.85%
50-day SMA	1,409
50-day SMA vs 200-day SMA	50under200
5Y total return	-35.2%
All Time High	6,020
All Time High Change	-76.91%
All Time High Date	2018-02-08
All Time Low	1,120
All Time Low Change	24.11%
All Time Low Date	2025-10-24
ATR	139.8
Beta	-0.1
Beta1y	0.35
Beta2y	0.11
Ch YTD	-11.69
High	1,390
High52	1,719
High52 Date	2025-12-09
High52ch	-19.43%
Low	1,257
Low52	1,120
Low52 Date	2025-10-24
Low52ch	23.66%
Ma50ch	-1.35%
Price vs 200-day SMA	-2.6%
RSI	48.25
RSI Monthly	40.51
RSI Weekly	48.25
Sharpe ratio	0.35x
Sortino ratio	0.6
Total Return	33.03%
Tr YTD	-11.69
Tr1m	-0.71%
Tr1w	-0.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 1B
Operating Income Growth	-39.51
Operating Income Growth3 Y	-23.13
Operating Income Growth5 Y	-14.2
Operating margin	2.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,591,766%
Net Borrowing	-7,595,215,240
Shares Institutions	0.61%
Shares Out	12,687,778

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 350.3M
Average Volume	1,343.8x
Bv Per Share	2,084.5
CAPEX	KRW -233.2M
Ch1m	-0.71
Ch1w	-0.71
Ch1y	2.58
Ch3y	-32.85
Ch5y	-35.2
Ch6m	0.07
Change	-0.36%
Change From Open	-0.36
Close	1,390
Days Gap	0
Depreciation Amortization	1,628,964,190
Dollar Volume	4,155
EBIT	KRW 1B
EBITDA	KRW 2.7B
EPS	KRW -57
F Score	6
FCF	KRW 350.3M
FCF Per Share	KRW 27.61
Financing CF	828,290,120
Fiscal Year End	December
Founded	1,992
Income Tax	KRW 45.8M
Investing CF	-392,413,440
Is Primary Listing	1
Last Report Date	2012-12-31
Ma150	1,404.6
Ma150ch	-1.04%
Ma20	1,413.7
Ma20ch	-1.67%
Net CF	1,019,612,000
Open	1,390
P FCF Ratio	50.17
P OCF Ratio	30.12
Position In Range	96.24
Ppne	24,056,277,870
Price Date	2026-05-08
Price EBITDA	KRW 6.62
Ptbv Ratio	1.54
Relative Volume	0x
Revenue	38,096,352,700x
Tax By Revenue	0.12x
Tr6m	0.07%
Volume	3
Z Score	0.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/086220 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/086220 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/086220?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/086220 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

-2.6%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/086220

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/086220 stock rating?

xkon/086220 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/086220 analysis?

The full report lives at /stocks/xkon/086220/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/086220?

The latest report frames xkon/086220 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/086220 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.